Jan 28, 2009 - Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. FDA for its Abbreviated New Drug Application for Lamotrigine Tablets 25 mg, 100 mg, 150 mg, and 200 mg. Taro had received tentative approval for this ANDA in March 2008.
The details can be read here.
No comments:
Post a Comment